{"id":584410,"url":"http://en.wikipedia.org/wiki/Henri_Termeer","text":"Henri A. Termeer (28 February 1946 \u2013 10 May 2017) was an American biotechnology executive and entrepreneur. He was called a pioneer in corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme.\nTermeer created a business model created by many others in the biotech industry by creating steep prices\u2014 mainly from insurers and government payers\u2014 for therapies for rare genetic disorders known as orphan diseases that mainly affect children. Genzyme uses biological processes to manufacture drugs that are not easily copied by generic-drug makers. He was born in Tilburg, Netherlands.\nTermeer died of a suspected aneurysm on 12 May 2017 at his home in Marblehead, Massachusetts, aged 71.","categories":[],"infobox_types":[],"annotations":[{"uri":"Biotechnology","surface_form":"biotechnology","offset":66},{"uri":"Genzyme","surface_form":"Genzyme","offset":209},{"uri":"Orphan_diseases","surface_form":"orphan diseases","offset":418},{"uri":"Tilburg","surface_form":"Tilburg","offset":584},{"uri":"Netherlands","surface_form":"Netherlands","offset":593},{"uri":"Aneurysm","surface_form":"aneurysm","offset":634},{"uri":"Marblehead%2C_Massachusetts","surface_form":"Marblehead","offset":673},{"uri":"Massachusetts","surface_form":"Massachusetts","offset":685}]}